Product
AZD6422
1 clinical trial
1 indication
Indication
Gastrointestinal TumorsClinical trial
FTiH, Phase 1 Investigator-Initiated Trial (IIT) to Evaluate the Safety, Feasibility, Cellular Kinetics, and Preliminary Antitumor Activity of AZD6422 in Adult Participants With Advanced or Metastatic CLDN18.2+ GI TumorsStatus: Recruiting, Estimated PCD: 2026-06-01